When gym-goers talk about ‘the pump,’ they’re describing the transient engorgement of muscle tissue with blood—a phenomenon driven primarily by nitric oxide (NO)-mediated vasodilation. Agmatine sulfate and L-citrulline both appear in pre-workout formulas carrying pump claims, but the biochemical stories behind each are remarkably different. Citrulline works upstream as a direct NO precursor, while agmatine operates as a neuromodulator and pleiotropic signaling molecule that interacts with NO pathways indirectly.
Understanding those distinctions matters if you want to make an informed choice rather than buying marketing copy. This article breaks down the proposed mechanisms of each compound, examines what peer-reviewed research actually suggests, and honestly notes where the evidence is thin or absent. Neither compound is FDA-approved to treat, diagnose, cure, or prevent any disease, and everything here is informational only.
Key Takeaways
- Citrulline works as a direct NO precursor by bypassing hepatic first-pass metabolism and replenishing plasma arginine more effectively than arginine supplementation itself [7].
- Agmatine modulates NO indirectly—it can upregulate eNOS [5] and activate imidazoline receptors to promote vascular relaxation [4], but also suppresses iNOS in immune cells [2]—making its net vascular effect tissue- and context-dependent.
- Citrulline has a stronger and more direct human exercise evidence base for pump and performance benefits [PMID 36771366, PMID 34965876]; agmatine’s exercise-relevant data remains largely mechanistic.
- The two compounds target different points in the vasodilation network and may be theoretically complementary, though human combination trials are absent from the literature.
- Neither compound is FDA-approved for any medical use; both have GI tolerability limits at higher doses and agmatine may interact with blood pressure medications, MAOIs, or opioids.
Citrulline's Direct Route to Nitric Oxide
L-citrulline earns its pump reputation through a well-characterized biochemical pathway. After oral ingestion, citrulline is transported to the kidneys, where it is converted back to L-arginine. That arginine then becomes the direct substrate for nitric oxide synthase (NOS) enzymes, which oxidize it to produce NO and—completing the cycle—citrulline again [6]. The reason citrulline outperforms arginine supplementation is intestinal and hepatic first-pass metabolism: a large fraction of orally ingested arginine is broken down before reaching systemic circulation, whereas citrulline bypasses this bottleneck efficiently [7].
The practical result is a more sustained elevation of plasma arginine and, by extension, NO bioavailability. A 2021 paper in Acta Physiologica concluded that endogenous NO flux is better maintained when citrulline serves as the substrate rather than arginine directly [7]. For athletes, higher circulating NO can promote vasodilation, improve oxygen and nutrient delivery to working muscle, and contribute to the visible vascular pump. A systematic review and meta-analysis examining dietary NO precursors including citrulline found some support for endurance exercise performance, though effects varied by population and protocol [8].
Agmatine's Indirect and Pleiotropic Approach
Agmatine is a biogenic amine formed when L-arginine is decarboxylated by arginine decarboxylase. Unlike citrulline, agmatine is not itself a substrate for NO synthase. Instead, it modulates NO production by acting on multiple receptor systems simultaneously—a property described as pleiotropic—giving it proposed roles across pain, mood, and vascular tone [1]. This creates a nuanced, and honestly more complicated, relationship with the pump.
The clearest proposed vascular mechanism involves imidazoline receptors. Research on rat aorta tissue demonstrated that endogenous imidazoline receptor ligands—of which agmatine is a primary candidate—produce endothelium-dependent relaxation, suggesting a vasodilatory effect that does not rely on direct arginine-to-NO conversion [4]. Separately, agmatine has been shown to upregulate endothelial NOS (eNOS) in cerebral endothelial cells, an effect that would theoretically support NO production in the vascular wall [5]. These findings hint at a pump pathway, but the data come primarily from cell and animal models rather than controlled human exercise trials.
Agmatine’s relationship with NOS is also isoform-dependent, which adds important complexity. Studies in microglia show agmatine suppresses inducible NOS (iNOS)-driven NO production [2]. This iNOS inhibition is generally considered beneficial from an inflammation-management standpoint, but it means agmatine does not uniformly ‘boost’ NO—it selectively modulates which NOS isoform is active and in which tissue context [1].
What the Research Says About Exercise Performance
Citrulline has more direct human exercise data than agmatine. A 2023 review in Nutrients examining NO precursors for strength performance found that citrulline supplementation—typically 6–8 g of L-citrulline or 8 g of citrulline malate—showed some evidence of benefit for muscular endurance, training volume, and perceived exertion in resistance-training contexts [9]. The meta-analytic evidence on endurance exercise lends modest support as well, with the caveat that effect sizes and consistency vary across studies [8].
For agmatine, controlled human exercise performance studies are sparse. The mechanistic data from cell and animal models [PMID 15028591, PMID 17588309] provide a biologically plausible rationale for vasodilatory benefits, but extrapolating those findings to resistance training at standard doses requires significant caution. Agmatine’s most robust human evidence pertains to pain modulation and neurological function rather than exercise hemodynamics. From a pure evidence-ranking standpoint, citrulline currently holds a stronger body of human trial data supporting a pump and performance benefit.
Complementary Rather Than Competing Mechanisms
Because agmatine and citrulline act through distinct pathways, they are not necessarily redundant in a pre-workout formula—they may be complementary. Citrulline feeds the arginine-NOS-NO pathway directly by replenishing plasma arginine more effectively than arginine supplementation itself [7], while agmatine may potentiate eNOS activity at the vascular wall [5] and modulate imidazoline receptor signaling that promotes endothelium-dependent relaxation [4]. In principle, the two compounds address different nodes of the vasodilation network.
That said, ‘complementary mechanisms on paper’ is not the same as ‘proven synergy in humans.’ Stack studies combining agmatine and citrulline in an exercise context are essentially absent from the peer-reviewed literature. The theoretical case exists; the empirical confirmation in trained athletes does not yet. Anyone combining both compounds is working ahead of the published evidence.
Dosing Considerations and Tolerability
Citrulline doses used in the performance literature typically fall in the 6–8 g range for L-citrulline, taken 30–60 minutes before exercise [9]. Citrulline malate formulations often use 8 g, though the citrulline content per gram is lower due to the malate component. Citrulline is generally well-tolerated, with gastrointestinal discomfort as the most commonly noted side effect at higher doses.
Agmatine is typically used at 500–2000 mg daily. At the lower end of this range it is generally well-tolerated; nausea and loose stools have been reported at higher doses. Because agmatine interacts with NMDA receptors and modulates NOS isoforms, individuals using blood pressure medications, MAOIs, or opioids should consult a physician before use. The evidence base for an optimal exercise-specific dose of agmatine remains thin compared to citrulline. These statements have not been evaluated by the FDA.
Honest Limits of the Evidence
A frank appraisal: much of the agmatine pump narrative is built on mechanistic and animal research rather than randomized controlled trials in humans performing resistance exercise. The imidazoline-receptor vasodilation data [4] and eNOS upregulation findings [5] are biologically plausible but do not confirm that agmatine produces a measurable pump in a lifter at standard supplemental doses. Citrulline’s evidence is more direct, but even there, effect sizes are modest and not every study is positive [PMID 34965876, PMID 36771366].
It is also worth noting that citrulline’s conversion to arginine and subsequent NO production faces competition from arginase, the enzyme that breaks down arginine through a separate pathway [3], meaning substrate availability alone does not fully determine NO output. NO biology is complex, context-dependent, and not completely captured by plasma citrulline or arginine levels alone. Treat pump supplements as one tool among many, not as a guaranteed outcome.
🛒 Where to Buy Agmatine
- Primaforce Agmatine SulfateLab-tested / studied
powder, 500 mg per serving, 200 servings per 100 g — Longtime bodybuilding-community standard; clean COA history and recognized by MPMD-adjacent audiences - NOW Foods Agmatine Sulfate 500 mg
capsules, 500 mg per capsule, 60 capsules — Trusted mass-market brand with NSF auditing; accessible for newcomers hesitant to measure powder - Nutricost Agmatine Sulfate
capsules, 500 mg per capsule, 120 capsules — Best-selling capsule on Amazon; competitive cost per dose, third-party tested - Double Wood Supplements Agmatine Sulfate
capsules, 500 mg per 2 capsules, 60 servings — Popular nootropics-adjacent brand; frequently purchased alongside other NMDA modulators by cognitive-enhancement buyers
As an Amazon Associate we earn from qualifying purchases. Shilajit quality varies widely — always choose a product with a published third-party heavy-metal test (COA) before buying.
A Note on the Evidence
Most agmatine pump evidence comes from cell and animal models rather than controlled human exercise trials, limiting direct extrapolation to supplement use; citrulline’s human data is more robust but effect sizes remain modest and vary across studies. Individuals using blood pressure medications, MAOIs, or opioids should consult a physician before using either compound, and nothing in this article constitutes medical advice.
Frequently Asked Questions
Which is better for pump, agmatine or citrulline?
Based on current evidence, citrulline has more direct human trial data supporting improved pump and muscular endurance during resistance exercise [9]. Agmatine has plausible vasodilatory mechanisms via imidazoline receptor activation [4] and eNOS upregulation [5], but controlled pump-specific trials in humans are lacking. If forced to choose one based on published evidence, citrulline is the stronger call.
Can I stack agmatine and citrulline together?
Theoretically, yes—they operate through different pathways and are not redundant. Citrulline feeds the substrate side of NO production [7] while agmatine acts on receptor and enzymatic regulation [PMID 15028591, PMID 17588309]. However, no peer-reviewed human trials have confirmed a synergistic pump or performance benefit from combining them, so stacking is currently ahead of the published evidence.
Why does agmatine affect nitric oxide differently than citrulline?
Citrulline is a metabolic precursor that increases arginine availability for NOS enzymes to generate NO [6]. Agmatine is a signaling molecule that modulates NOS isoforms selectively—upregulating eNOS while inhibiting iNOS—and also acts on imidazoline receptors to promote endothelium-dependent vascular relaxation [PMID 10924686, PMID 15028591, PMID 17588309]. One supplies raw material to the pathway; the other adjusts the regulatory machinery around it.
What dose of citrulline is used in exercise studies?
Most resistance-exercise research uses 6–8 g of L-citrulline or 8 g of citrulline malate, taken approximately 30–60 minutes before training [9]. Citrulline’s pharmacokinetics are well-characterized enough that this dosing range is considered reasonable for supporting NO production, given its superior absorption compared to arginine [7].
Does citrulline actually raise nitric oxide levels?
Research supports that citrulline supplementation raises plasma arginine more effectively than direct arginine supplementation due to better intestinal absorption and bypass of hepatic first-pass metabolism [7]. Elevated plasma arginine provides substrate for eNOS to generate NO. A 2019 clinical study also showed L-citrulline improved NO production in a population with NO deficiency , supporting the mechanistic link, though results in healthy athletes may differ.
Is agmatine safe to use before workouts?
Agmatine is generally considered well-tolerated at 500–2000 mg daily, with nausea and loose stools reported at the higher end of this range. These statements have not been evaluated by the FDA and agmatine is not approved to treat or prevent any disease. Because it interacts with NMDA receptors and modulates multiple NOS isoforms, individuals using blood pressure medications, MAOIs, or opioids should consult a physician before use. This is informational, not medical advice.
References
- Blantz RC et al. Biological effects of arginine metabolites. Acta physiologica Scandinavica (2000). PMID 10691775
- Abe K et al. Agmatine suppresses nitric oxide production in microglia. Brain research (2000). PMID 10924686
- Mills CD et al. Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Critical reviews in immunology (2001). PMID 11942557
- Musgrave IF et al. Endogenous imidazoline receptor ligands relax rat aorta by an endothelium-dependent mechanism. Annals of the New York Academy of Sciences (2003). PMID 15028591
- Yang MZ et al. Agmatine inhibits matrix metalloproteinase-9 via endothelial nitric oxide synthase in cerebral endothelial cells. Neurological research (2007). PMID 17588309
- El-Hattab AW et al. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Molecular genetics and metabolism (2012). PMID 22819233
- Bahadoran Z et al. Endogenous flux of nitric oxide: Citrulline is preferred to Arginine. Acta physiologica (Oxford, England) (2021). PMID 33089645
- d'Unienville NMA et al. Effect of food sources of nitrate, polyphenols, L-arginine and L-citrulline on endurance exercise performance: a systematic review and meta-analysis of randomised controlled trials. Journal of the International Society of Sports Nutrition (2021). PMID 34965876
- Gonzalez AM et al. Supplementation with Nitric Oxide Precursors for Strength Performance: A Review of the Current Literature. Nutrients (2023). PMID 36771366
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.